The Year in US Regulatory Activity for Biosimilars

Season 2 Episode 32  ·  Dec 29, 2019, 06:00 AM
Headliner
Share
Subscribe
When it comes to US biosimilars, 2019 was a busy year for regulatory activity. This week on the podcast, we're rounding up the key developments of the year. 
Share
Subscribe
Next
Goodwin Attorneys Give a Look at Biosimilar Litigation
Top episodes
Dr. Sang-Jin Pak Talks Biosimilar Markets: US vs Europe
by Not So Different: A Podcast from The Center for Biosimilars
Dr Sang-Jin Pak Talks Biosimilar Market Stability
by Not So Different: A Podcast from The Center for Biosimilars
Ryan Haumschild, PharmD, Discusses Plan to Increase Biosimilar Utilization
by Not So Different: A Podcast from The Center for Biosimilars